ClinicalTrials.Veeva

Menu

Evaluation of Different G6PD Testing Platforms

P

People Acting To Help (PATH)

Status

Completed

Conditions

Glucose-6-Phosphate Dehydrogenase Deficiency

Study type

Observational

Funder types

Other

Identifiers

NCT02104518
Eijkman-69

Details and patient eligibility

About

In this study the investigators propose to evaluate the performance of several G6PD testing platforms.

Full description

In this study we propose to evaluate the performance of several G6PD testing platforms. We will also determine the concordance between point-of-care G6PD tests and the spectrophotometric gold standard. This study will also access the sensitivity and specificity between the point-of-care G6PD tests. This study will take place in Indonesia, specifically in the SW Sumba region. We will enroll 700 volunteers.

Enrollment

700 patients

Sex

All

Ages

5+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subjects must be at least five years of age
  • Patient / parental consent
  • Patient willing to allow donated sample to be used in future research

Exclusion criteria

  • Patients with severe malaria or other severe illness
  • Patients who received a blood transfusion in the last three months
  • Patients unwilling to allow donated blood to be used in future research

Trial design

700 participants in 1 patient group

G6PD testing
Description:
Blood samples will be tested for G6PD activity levels

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems